Thousands of hospitals, large and small, are girding for cuts to their Medicare payments in 2014, as federal pay-for-performance programs aimed at boosting clinical quality, improving patient experience and preventing unnecessary hospital readmissions roll into their second year.
Thousands of hospitals, large and small, are girding for cuts to their Medicare payments in 2014, as federal pay-for-performance programs aimed at boosting clinical quality, improving patient experience and preventing unnecessary hospital readmissions roll into their second year.
Officials at many hospitals, particularly academic medical centers, say they also fear an additional financial hit that may come next October, when the CMS is scheduled to launch the third and final pay-for-performance program established by the Patient Protection and Affordable Care Act. That initiative, the hospital-acquired condition reduction program, will reduce fiscal 2015 Medicare payments by 1% for hospitals that fall within the worst-performing quartile, based on measures of adverse events that occur during hospital stays, including infections and pressure ulcers.
Together with the CMS' value-based purchasing and readmissions reduction programs, both of which began in fiscal 2013, the three initiatives are part of a sweeping effort to move the agency toward paying for high-value care. While quality experts and hospital leaders laud the goals of the HAC reduction program, they have a lengthy list of concerns, including issues with the measures the CMS chose, the potential for multiple penalties under overlapping programs, and the prospect that teaching hospitals will be disproportionately affected. They question whether the programs will actually help hospitals achieve better quality care, and warn that the combined impact of penalties from three pay-for-performance programs could hurt some hospitals.
Read the full story here: http://bit.ly/1aOd6SU
Source: Modern Healthcare
Real-World Data Show Sotorasib Effective for NSCLC With KRAS Mutation
May 18th 2024Data from real-world and clinical-trial settings on frontline monotherapy treatment with the KRAS inhibitor sotorasib both show similar progression-free survivals and a high likelihood that the treatment’s efficacy is not affected with dose reduction.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Health Equity and Access Weekly Roundup: May 18, 2024
May 18th 2024The US Senate hosted a panel addressing physician and health care shortages and efforts to increase minority representation in the medical field. An expert discussed initiatives to prevent senior homelessness. Advocates called for the repeal of the Comstock Act. Regulatory reforms are called for to improve rural cancer patients' access to pharmacies. Research reveals the impact of denials on patient access to immunology treatments.
Read More